7-114629882-GCAGCAGCAACAA-GCAGCAGCAACAACAGCAGCAACAA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_014491.4(FOXP2):​c.495_506dupACAACAGCAGCA​(p.Gln166_Gln169dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.000365 in 1,611,820 control chromosomes in the GnomAD database, including 1 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 1 hom. )

Consequence

FOXP2
NM_014491.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 5.77

Publications

0 publications found
Variant links:
Genes affected
FOXP2 (HGNC:13875): (forkhead box P2) This gene encodes a member of the forkhead/winged-helix (FOX) family of transcription factors. It is expressed in fetal and adult brain as well as in several other organs such as the lung and gut. The protein product contains a FOX DNA-binding domain and a large polyglutamine tract and is an evolutionarily conserved transcription factor, which may bind directly to approximately 300 to 400 gene promoters in the human genome to regulate the expression of a variety of genes. This gene is required for proper development of speech and language regions of the brain during embryogenesis, and may be involved in a variety of biological pathways and cascades that may ultimately influence language development. Mutations in this gene cause speech-language disorder 1 (SPCH1), also known as autosomal dominant speech and language disorder with orofacial dyspraxia. Multiple alternative transcripts encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
FOXP2 Gene-Disease associations (from GenCC):
  • specific language disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood apraxia of speech
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_014491.4
BP6
Variant 7-114629882-G-GCAGCAGCAACAA is Benign according to our data. Variant chr7-114629882-G-GCAGCAGCAACAA is described in ClinVar as Likely_benign. ClinVar VariationId is 242948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000371 (56/150754) while in subpopulation NFE AF = 0.000459 (31/67570). AF 95% confidence interval is 0.000332. There are 0 homozygotes in GnomAd4. There are 34 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 56 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXP2NM_014491.4 linkc.495_506dupACAACAGCAGCA p.Gln166_Gln169dup disruptive_inframe_insertion Exon 5 of 17 ENST00000350908.9 NP_055306.1 O15409-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXP2ENST00000350908.9 linkc.495_506dupACAACAGCAGCA p.Gln166_Gln169dup disruptive_inframe_insertion Exon 5 of 17 1 NM_014491.4 ENSP00000265436.7 O15409-1

Frequencies

GnomAD3 genomes
AF:
0.000372
AC:
56
AN:
150636
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00463
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000424
Gnomad FIN
AF:
0.0000953
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000459
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000359
AC:
89
AN:
247926
AF XY:
0.000350
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00310
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000929
Gnomad NFE exome
AF:
0.000334
Gnomad OTH exome
AF:
0.000987
GnomAD4 exome
AF:
0.000365
AC:
533
AN:
1461066
Hom.:
1
Cov.:
32
AF XY:
0.000367
AC XY:
267
AN XY:
726824
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33472
American (AMR)
AF:
0.000179
AC:
8
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.00533
AC:
139
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39626
South Asian (SAS)
AF:
0.0000929
AC:
8
AN:
86112
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53296
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5760
European-Non Finnish (NFE)
AF:
0.000291
AC:
324
AN:
1111694
Other (OTH)
AF:
0.000646
AC:
39
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000371
AC:
56
AN:
150754
Hom.:
0
Cov.:
33
AF XY:
0.000462
AC XY:
34
AN XY:
73588
show subpopulations
African (AFR)
AF:
0.000146
AC:
6
AN:
41066
American (AMR)
AF:
0.00
AC:
0
AN:
15104
Ashkenazi Jewish (ASJ)
AF:
0.00463
AC:
16
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5068
South Asian (SAS)
AF:
0.000424
AC:
2
AN:
4718
European-Finnish (FIN)
AF:
0.0000953
AC:
1
AN:
10492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000459
AC:
31
AN:
67570
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000988
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FOXP2: BS2 -

Mar 03, 2015
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Childhood apraxia of speech Benign:1Other:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Speech: CAS -

FOXP2-related disorder Benign:1
Oct 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.8
Mutation Taster
=66/34
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761316361; hg19: chr7-114269937; API